Performance of 177Lu-PSMA-I&T for RLT in mCRPC - Prospective Multicenter Swiss Registry Study

NCT06830408 · clinicaltrials.gov ↗

COMPLETED

Status

250

Enrollment

OTHER

Sponsor class

Conditions

mCRPC

Interventions

DRUG: radionuclide therapy with 177Lu-PSMA-I&T

Sponsor

University Hospital, Basel, Switzerland